 | | | | (Reuters) - Pfizer Inc's Retacrit was approved by U.S. health regulators as a biosimilar to current anemia treatments from Amgen Inc and Johnson & Johnson on Tuesday, setting it up to compete against more established brands. | | | | | | VEVEY, Switzerland (Reuters) - Nestle will make further cuts to the amount of sugar, salt and saturated fats in its products as it tries to improve the image of packaged foods in the eyes of health-conscious consumers, the Swiss group said on Tuesday. Nestle and its rivals are under pressure from a shift in consumer preferences toward healthier food and away from processed products such as instant noodles and frozen pizza. | | | | | | COPENHAGEN/FRANKFURT (Reuters) - Hearing aid makers Widex and Sivantos agreed to merge on Wednesday to form the world's third-largest supplier behind market leaders Sonova and William Demant. | | | | | | CHICAGO (Reuters) - Thomas DeRosa is making a $4 billion bet that he can build a national, low-cost healthcare network for America's aging population that will succeed where so many other models have struggled. | | | | | | NEW YORK (Reuters) - Litigation against OxyContin maker Purdue Pharma LP is intensifying as six more U.S. states on Tuesday announced lawsuits, accusing the company of fueling a national opioid epidemic by deceptively marketing its prescription painkillers to generate billions of dollars in sales. | | | | | | SYDNEY/WELLINGTON (Reuters) - Stay-at-home mother Anna Wei wanted the best milk formula to feed her firstborn, so she chose the most expensive brand her money could buy: Platinum by a2 Milk Company Ltd. | | | | | | (Reuters) - Planned Parenthood and the American Civil Liberties Union's Iowa branch said they sued on Tuesday to stop a state law that would impose the strictest abortion limits in the United States from taking effect. | | | | | | (Reuters Health) - Schoolbag use doesn't appear to increase the risk of back pain in children and adolescents, according to an Australian review of previous studies. | | | | | | (Reuters Health) - When type 2 diabetes isn't well controlled with oral medications, doctors are often slow to switch patients to more intensive treatment, a U.S. study suggests. | | | | | | (Reuters Health) - Both men and women who are overweight or obese may be more likely to develop an irregular heart rhythm condition known as atrial fibrillation than their counterparts who maintain a healthy weight, a recent study suggests. | | | | | |
